Standard BioTools Inc. (NASDAQ:LAB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Incoporated First Quarter 2023 Financial Results Conference Call. As a reminder, this conference is being recorded.
Standard Biotools Inc. (LAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 32,748,000 | $34,093,943 | 10.54% | ||
| 2. | Indaba Capital Management Derek C. Schrier | 7,446,229 | $14,520,147 | 4.48% | |
| 3. | 9,500,000 | $9,683,312 | 0.37% | ||
| 4. | D E Shaw D. E. Shaw | 580,503 | $1,131,981 | -27% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 113,518 | $221,360 | +416% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.29 | 42,492 | Officer | 85,984 | 2023-05-19 | Filing | |
| $2.22 | 43,492 | Officer | 43,492 | 2023-05-18 | Filing | |
| $2.29 | 800,000 | Large Shareholder, Director | 1,200,000 | 2023-05-19 | Filing | |
| $2.16 | 150,000 | Large Shareholder, Director | 400,000 | 2023-05-18 | Filing | |
| $1.89 | 250,000 | Large Shareholder, Director | 250,000 | 2023-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.06 | 84,820 | Officer | 145,347 | 2020-11-23 | Filing | |
| $5.40 | 577,197 | Large Shareholder, Other | 6,909,871 | 2019-09-17 | Filing | |
| $5.55 | 10,038 | Large Shareholder, Other | 7,487,068 | 2019-09-11 | Filing | |
| $5.56 | 1,507 | Large Shareholder, Other | 7,497,106 | 2019-09-11 | Filing | |
| $7.01 | 151,011 | Large Shareholder, Other | 8,271,611 | 2019-08-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 8,576,799 | $16,724,758 | 11.66% | |
| 2. | 4,508,776 | $8,810,749 | 0% | |
| 3. | 4,497,573 | $8,770,267 | 0% | |
| 4. | 7,752,000 | $8,095,000 | 0% | |
| 5. | 3,955,968 | $7,714,137 | 0% |
News See All
Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
5 Best Micro-Cap Stocks to Buy According to Hedge Funds
In this article, we discuss the 5 best micro-cap stocks to buy according to hedge funds.
Billionaire Hedge Funds
